Connect
MJA
MJA

Hepatitis C: where are we at and where are we going?

Robert G Batey
Med J Aust 2002; 176 (8): 361-362.
Published online: 15 April 2002

We are making progress in our understanding of the hepatitis C virus, but there is still a long way to go

The identification of the hepatitis C virus (HCV) in 19891 delineated a disease previously masquerading under the title of "non-A, non-B hepatitis". In the ensuing years, hepatitis C has become a national epidemic, with more than 150 000 Australians known to be infected. It is estimated that an additional 11 000 new infections occurred each year during the 1990s.2 Escalating rates of HCV infection will have enormous consequences, as 10%–15% of people infected have the potential to progress to end-stage liver disease, with all the implications that has for healthcare services in the years ahead.3

  • Robert G Batey

  • Division of Medicine, John Hunter Hospital, Newcastle, NSW.


Author

remove_circle_outline Delete Author
add_circle_outline Add Author

Comment
Do you have any competing interests to declare? *

I/we agree to assign copyright to the Medical Journal of Australia and agree to the Conditions of publication *
I/we agree to the Terms of use of the Medical Journal of Australia *
Email me when people comment on this article

Responses are now closed for this article.